Back to NRIX
Candriam S.C.A. NRIX Position History
Nurix Therapeutics, Inc.
Quarters held
6
Latest value
$8.8M
Q3 2026
Peak value
$10.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $2.4M |
| Q4 2025 | $10.1M |
| Q4 2025 | $10.1M |
| Q1 2026 | $8.3M |
| Q2 2026 | $9.2M |
| Q3 2026 | $8.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $8.8M | 371.3K | — | — |
| Q2 2026 | $9.2M | 377.9K | — | — |
| Q1 2026 | $8.3M | 534.3K | — | — |
| Q4 2025 | $10.1M | 534.3K | — | — |
| Q4 2025 | $10.1M | 534.3K | — | — |
| Q3 2025 | $2.4M | 262.4K | — | — |
Other funds holding NRIX
$113.5M
$113.5M
$107.5M
$85.7M
$79.7M
$71.8M